Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 03 Jan 2023 for Eiger BioPharmaceuticals, Inc., €5,743. Read the official filing
Filing timeline
BuySaleChristine Murray
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Christine Murray: trading record in brief
Christine Murray (board member) discloses dealings in Eiger BioPharmaceuticals, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 11 March 2022 to 29 December 2022.
The open-market record consists of 1 sale worth €5,743, with no purchase. Other entries cover 1 share grant. So far in 2023, the count stands at no purchases and 1 sale.
Most recently, on 3 January 2023, the filings show an open-market sale worth €5,743 in Eiger BioPharmaceuticals, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christine Murray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
5,000 shares@ US$1.2208100.0% of flowCommon StockSEC:0001567619-23-000069:0
6,000 shares0Common StockSEC:0001140361-22-009261:0
2 of 2 declarations
